Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
74.31
-1.68 (-2.21%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
3,7331,9851,376719486511
Upgrade
Market Cap Growth
56.43%44.25%91.51%47.79%-4.80%-7.70%
Upgrade
Enterprise Value
3,7482,0181,378535299380
Upgrade
Last Close Price
74.3141.3529.5219.5015.9517.46
Upgrade
PS Ratio
8.425.897.389.3225.41-
Upgrade
PB Ratio
14.588.805.535.064.042.97
Upgrade
P/TBV Ratio
215.94--8.654.792.97
Upgrade
P/FCF Ratio
432.73212.71----
Upgrade
P/OCF Ratio
415.03192.25----
Upgrade
EV/Sales Ratio
8.735.997.396.9515.62-
Upgrade
EV/FCF Ratio
434.39216.27----
Upgrade
Debt / Equity Ratio
1.251.411.240.020.020.02
Upgrade
Debt / FCF Ratio
36.9734.05----
Upgrade
Asset Turnover
0.620.510.370.240.07-
Upgrade
Inventory Turnover
4.153.653.383.50--
Upgrade
Quick Ratio
2.842.834.072.723.7612.56
Upgrade
Current Ratio
3.133.104.452.943.9112.80
Upgrade
Return on Equity (ROE)
-24.19%-37.08%-83.65%-103.46%-57.47%-68.29%
Upgrade
Return on Assets (ROA)
-5.15%-8.31%-13.65%-25.33%-40.48%-33.64%
Upgrade
Return on Capital (ROIC)
-6.37%-9.95%-19.46%-61.42%-72.69%-42.14%
Upgrade
Earnings Yield
-1.57%-4.43%-11.88%-18.88%-17.27%-20.22%
Upgrade
FCF Yield
0.23%0.47%-5.16%-16.76%-27.31%-17.48%
Upgrade
Buyback Yield / Dilution
-6.94%-16.23%-20.31%-12.07%-20.08%-119.84%
Upgrade
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q